<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2019-02-25">25/02/2019</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Leonard</forename><forename type="middle">G</forename><surname>Nanao</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>De Sanctis</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Melnikov</surname></persName>
						</author>
						<author>
							<persName><forename type="first">James</forename><surname>Irving</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">School of Pharmacy &amp; NPP</orgName>
								<orgName type="institution">ISMB application</orgName>
								<address>
									<settlement>Birkbeck</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">UCL; Biological and Chemical Sciences</orgName>
								<orgName type="institution">Queen Mary College</orgName>
								<address>
									<settlement>London. Irving group</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Institute of Structural and Molecular Biology</orgName>
								<orgName type="institution">University of London UCL</orgName>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-02-25">25/02/2019</date>
						</imprint>
					</monogr>
					<idno type="MD5">A64E18730149784CB8E0B275B1A15783</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T14:21+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>We have been characterising mutants of the disease-associated plasma protein alpha-1-antitrypsin (AAT) and conformationally-selective antibodies that act as probes of structural change. We have also expended effort attempting to obtain high resolution structures of AAT bound to small molecules, which has necessitated screening of a significant number of crystals. Structures of mutants with substitutions that modify packing in the 'breach' regulatory site of AAT have been solved, as have structures of Fab domains both alone and in complex with AAT. The latter have been used to interpret single-particle reconstructions from negative stain images of oligomers isolated from patients and decorated with Fabs; these data are being written up into two manuscripts which will be submitted in due course. One of the Fab complexes is with an antibody that is being used to screen patient plasma and will represent a third paper.</p><p>The following structures have been deposited at the PDB based on ESRF data, with three more to be deposited in due course:</p><p>6HX4 "Fab fragment of a native monomer-selective antibody in complex with alpha-1-antitrypsin" ESRF ID30B</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body/>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>from: 21/04/2018 to: 22/04/2018 from: 11/06/2018 to: 12/06/2018 from: 12/07/2018 to: 13/07/2018 from: 1/12/2018 to: 02/12/2018</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin in complex with its antigen</title>
		<author>
			<persName><forename type="first">M</forename><surname>Laffranchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L K</forename><surname>Elliston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Miranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Jagger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Irving</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb6i3z/pdb</idno>
	</analytic>
	<monogr>
		<title level="j">ESRF ID</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<date type="published" when="2019-11-20" />
			<publisher>Worldwide Protein Data Bank</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">&quot;Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin in complex with its antigen&quot; ESRF ID29</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Fab fragment of an antibody that inhibits polymerisation of alpha-1-antitrypsin</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Jagger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Heyer-Chauhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Irving</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb6qu9/pdb</idno>
		<imprint>
			<date type="published" when="2019-02-26" />
			<publisher>Worldwide Protein Data Bank</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">6QU9 &quot;Fab fragment of an antibody that inhibits polymerisation of alpha-1-antitrypsin&quot; ESRF ID30B</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
